Tarsus Pharmaceuticals Inc (TARS)

Finanzdaten der Tarsus Pharmaceuticals Inc-Aktie (TARS)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	7.32%173.91	162.05	151.67	118.70	102.66
Cost Of Revenue	28.92%12.11	9.40	-	-	-
	10.46%150.70	136.43	-	-	-
Selling, General, and Administrative	10.46%150.70	136.43	-	-	-
Research and Development	38.74%31.01	22.35	-	-	-
Costs And Expenses	15.25%193.82	168.18	159.64	133.23	124.84
Operating Income/Loss	225.19%-19.91	-6.12	-7.98	-14.53	-22.18
Nonoperating Income/Loss	170.27%4.07	1.51	1.66	1.94	1.84
Income Tax Expense/Benefit	15.48%2.72	2.35	-	-	-
	166.27%-18.55	-6.97	-8.37	-12.59	-20.34
Attributable To Parent	166.27%-18.55	-6.97	-8.37	-12.59	-20.34
Basic Average Shares	1.02%43.39	42.96	0.33	42.61	42.36
Diluted Average Shares	1.02%43.39	42.96	0.33	42.61	42.36
Basic Earnings Per Share	168.75%-0.43	-0.16	-0.19	-0.30	-0.48
Diluted Earnings Per Share	168.75%-0.43	-0.16	-0.19	-0.30	-0.48